Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Operations

v3.20.1
Consolidated Statement of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Net revenue $ 62,027 $ 84,635
Cost of net revenue 31,265 39,558
Gross profit 30,762 45,077
Operating expenses:    
Research and development 25,689 27,399
Selling, general and administrative 24,632 23,591
Impairment losses 86 0
Restructuring charges 489 1,917
Total operating expenses 50,896 52,907
Loss from operations (20,134) (7,830)
Interest income 225 147
Interest expense (2,476) (2,975)
Other income (expense), net 180 (655)
Total interest and other income (expense), net (2,071) (3,483)
Loss before income taxes (22,205) (11,313)
Income tax benefit (6,736) (6,462)
Net loss $ (15,469) $ (4,851)
Net loss per share:    
Basic (usd per share) $ (0.21) $ (0.07)
Diluted (usd per share) $ (0.21) $ (0.07)
Shares used to compute net loss per share:    
Basic (shares) 72,039 69,968
Diluted (shares) 72,039 69,968